Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
Saved in:
| Title: | Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates. |
|---|---|
| Authors: | Pascal KE; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Dudgeon D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Trefry JC; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Anantpadma M; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Sakurai Y; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Murin CD; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California., Fairhurst J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Torres M; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Rafique A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Yan Y; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Badithe A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Yu K; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Potocky T; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Bixler SL; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Chance TB; Pathology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Pratt WD; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Rossi FD; Center for Aerobiological Sciences, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Shamblin JD; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Wollen SE; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Zelko JM; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Carrion R Jr; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Worwa G; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Staples HM; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Burakov D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Babb R; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Chen G; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Martin J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Huang TT; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Erlandson K; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Willis MS; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Armstrong K; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Dreier TM; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California., Davey RA; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Pitt MLM; Office of the Commander, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Lipsich L; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Mason P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Olson W; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Stahl N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Kyratsous CA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S612-S626. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiy285 |
